IN
Healthcare & Life Sciences
Inimmune
United Statesinimmune.com
Inimmune is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Inimmune
Inimmune is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Inimmune is a clinical-stage biotech company developing novel immunotherapies and vaccine adjuvants that harness the innate immune system to treat inflammatory diseases including allergies, cancer, and autoimmune conditions.
Explore Inimmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.